Recruitment

Recruitment Status
Completed

Inclusion Criterias

A prescription filled for statin medication within the last 12 months
Medication Possession Ratio (MPR) <80%
CVS Caremark Beneficiary
...
A prescription filled for statin medication within the last 12 months
Medication Possession Ratio (MPR) <80%
CVS Caremark Beneficiary
LDL > or = 130 mg/dl - measured during screening
Diabetes and or history of CVD

Exclusion Criterias

Co-morbidities likely to lead to death within a short-period
Contraindication to further statin use or have suffered side effects from statins, such as myopathy
Will not or cannot give consent
...
Co-morbidities likely to lead to death within a short-period
Contraindication to further statin use or have suffered side effects from statins, such as myopathy
Will not or cannot give consent
History of active or progressive liver disease or abnormal liver function tests on baseline screening
Less than 18 years old
Currently participating in another clinical trial with related aims

Summary

Conditions
Diabetes
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Single (Investigator)
  • Primary Purpose: Other

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Inclusion Criterias

A prescription filled for statin medication within the last 12 months
Medication Possession Ratio (MPR) <80%
CVS Caremark Beneficiary
...
A prescription filled for statin medication within the last 12 months
Medication Possession Ratio (MPR) <80%
CVS Caremark Beneficiary
LDL > or = 130 mg/dl - measured during screening
Diabetes and or history of CVD

Exclusion Criterias

Co-morbidities likely to lead to death within a short-period
Contraindication to further statin use or have suffered side effects from statins, such as myopathy
Will not or cannot give consent
...
Co-morbidities likely to lead to death within a short-period
Contraindication to further statin use or have suffered side effects from statins, such as myopathy
Will not or cannot give consent
History of active or progressive liver disease or abnormal liver function tests on baseline screening
Less than 18 years old
Currently participating in another clinical trial with related aims

Locations

Philadelphia, Pennsylvania, 19104
Philadelphia, Pennsylvania, 19104

Tracking Information

NCT #
NCT02086539
Collaborators
  • Rutgers University
  • National Institute on Aging (NIA)
Investigators
  • Principal Investigator: Kevin G Volpp, MD, PhD University of Pennsylvania
  • Kevin G Volpp, MD, PhD University of Pennsylvania